Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management, Clin Microbiol Rev, vol.28, issue.3, pp.603-61, 2015. ,
The outcome of bacterial arthritis: a prospective community-based study, Arthritis Rheum, vol.40, issue.5, pp.884-92, 1997. ,
Deficiency of the complement component 3 but not factor B aggravates Staphylococcus aureus septic arthritis in mice, Infect Immun, vol.84, issue.4, pp.930-939, 2016. ,
Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus, Infect Immun, vol.65, issue.7, pp.2517-2538, 1997. ,
Role of macrophages in Staphylococcus aureusinduced arthritis and sepsis, Arthritis Rheum, vol.43, issue.10, pp.2276-82, 2000. ,
Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci, Eur J Immunol, vol.24, issue.5, pp.1161-1167, 1994. ,
The fall of a dogma? Unexpected high T-cell memory response to Staphylococcus aureus in humans, J Infect Dis, vol.212, issue.5, pp.830-838, 2015. ,
Defining immunological dysfunction in sepsis: a requisite tool for precision medicine, J Inf Secur, vol.72, issue.5, pp.525-561, 2016. ,
A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection, J Immunol, vol.194, issue.3, pp.1100-1111, 2015. ,
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat Genet, vol.27, issue.1, pp.20-21, 2001. ,
Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases, Nat Rev Immunol, vol.10, issue.12, pp.849-59, 2010. ,
Chaudhry a, deRoos P, Rudensky a, Sparwasser T: cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice, J Immunol, vol.183, issue.12, pp.7631-7635, 2009. ,
CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game, J Immunol, vol.187, issue.5, pp.2061-2067, 2011. ,
FOXP3+ regulatory T cells in the human immune system, Nat Rev Immunol, vol.10, issue.7, pp.490-500, 2010. ,
Clinical immunity in bone and joints, J Bone Miner Metab, vol.37, issue.1, pp.2-8, 2019. ,
Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells, J Immunol, vol.185, issue.11, pp.6426-6456, 2010. ,
Revisiting IL-2: Biology and therapeutic prospects, Sci Immunol, vol.3, 2018. ,
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases, Nat Rev Immunol, vol.15, issue.5, pp.283-94, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01617541
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial, Lancet Diabetes Endocrinol, vol.1, issue.4, pp.295-305, 2013. ,
Interleukin-2 and regulatory T cells in graft-versus-host disease, N Engl J Med, vol.365, issue.22, pp.2055-66, 2011. ,
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients, J Autoimmun, vol.58, pp.48-58, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01112156
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis, N Engl J Med, vol.365, issue.22, pp.2067-77, 2011. ,
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial, Ann Rheum Dis, vol.78, issue.2, pp.209-226, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01980090
Staphylococcus aureus strategies to evade the host acquired immune response, Int J Med Microbio, vol.308, issue.6, pp.625-655, 2017. ,
Outbreak of spontaneous staphylococcal arthritis and osteitis in mice, Arthritis Rheum, vol.33, pp.1739-1783, 1990. ,
In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9, Diabetologia, vol.54, issue.5, pp.1075-86, 2011. ,
CTLA4 immunoglobulin but not anti-tumor necrosis factor therapy promotes staphylococcal septic arthritis in mice, J Infect Dis, vol.212, issue.8, pp.1308-1324, 2015. ,
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells, J Exp Med, vol.207, issue.9, pp.1871-1879, 2010. ,
The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice, J Infect Dis, vol.204, issue.3, pp.348-57, 2011. ,
Radiological features of experimental staphylococcal septic arthritis by micro computed tomography scan, PLoS One, vol.12, issue.2, p.171222, 2017. ,
Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancer, Clin Immunol, vol.151, issue.2, pp.114-140, 2014. ,
Histopathological and serological progression of experimental Staphylococcus aureus arthritis, Infect Immun, vol.60, issue.7, pp.2976-85, 1992. ,
Clinical features and outcome of septic arthritis in a single UK Health District, 1982. ,
, Ann Rheum Dis, vol.58, issue.4, pp.214-223, 1999.
The biology of interleukin-2, Annu Rev Immunol, vol.26, pp.453-79, 2008. ,
Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis, Clin Exp Immunol, vol.117, issue.1, pp.63-72, 1999. ,
Are B lymphocytes of importance in severe Staphylococcus aureus infections?, Infect Immun, vol.68, issue.5, pp.2431-2435, 2000. ,
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17, Rheumatology (Oxford), vol.47, issue.11, pp.1635-1675, 2008. ,
Interleukin-17A during local and systemic Staphylococcus aureus-induced arthritis in mice, Infect Immun, vol.78, issue.9, pp.3783-90, 2010. ,
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae, J Immunol, vol.169, issue.6, pp.3353-62, 2002. ,
Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways, J Biol Chem, vol.276, issue.1, pp.563-571, 2001. ,
Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance, Clin Exp Immunol, vol.130, issue.3, pp.409-423, 2002. ,
Staphylococcus aureus controls interleukin-5 release in upper airway inflammation, J Proteome, vol.180, pp.53-60, 2018. ,
Protection against Staphylococcus aureus bacteremia-induced mortality depends on ILC2s and eosinophils, JCI Insight, vol.4, 2019. ,
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus, Nat Med, vol.22, issue.9, pp.991-994, 2016. ,
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus, Ann Rheum Dis, vol.75, issue.7, pp.1407-1422, 2016. ,
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease, Sci Transl Med, vol.5, issue.179, pp.179-143, 2013. ,
Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells, Atherosclerosis, vol.220, issue.2, pp.329-365, 2012. ,
Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis, Circulation, vol.126, issue.10, pp.1256-66, 2012. ,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations